Early Intratracheal Budesonide to Reduce Bronchopulmonary Dysplasia in Extremely Preterm Infants

Overview of attention for article published in JAMA: Journal of the American Medical Association, October 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

news: 3 news outlets
blogs: 3 blogs
twitter: 43 X users

facebook: 2 Facebook pages
guideline: 1 clinical guideline source
bluesky: 10 Bluesky users

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 3 news stories from 3 outlets.

Featured Buzz December 1, 2025

AARC, 01 Dec 2025

By Debbie Bunch December 1, 2025 New Hope for Patients with Sepsis-Induced Lung Injury Patients who suffer from acute lung…

Esteróides intratraqueais não mostram nenhum benefício

PortalEnf Comunidade de Saúde, 17 Nov 2025

Publicidade - continue a ler a seguir Crédito: CC0 Domínio Público Um ensaio clínico multicêntrico descobriu que os esteroides…

Budesonide-Surfactant Shows No Lung Benefit in Preemies

Medscape, 14 Oct 2025

TOPLINE: Intratracheal administration of budesonide mixed with surfactant did not reduce the rates of bronchopulmonary…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.